FEATURED ARTICLES
-
Planning For Scale Up: Building For Long Term Flexibility
Decisions made during clinical manufacturing have lasting consequences at commercial scale. This article examines how fill/finish equipment choices shape long-term flexibility, throughput, and operational continuity.
WHITE PAPERS & CASE STUDIES
-
SEDDS: Improving Oral Bioavailability Of Poorly Soluble Compounds
Nearly 90% of marketed drugs have poor water solubility. Learn how self-emulsifying drug delivery systems (SEDDS) resolve oral bioavailability failures across BCS Class II and IV compounds.
-
From API Synthesis To Drug Product Shelf Life
Fragmented drug development causes delays and added costs. Unifying API synthesis, fill-finish, and testing streamlines logistics, preserves product data, and accelerates regulatory timelines.
-
Scaling A Sterile Fill-Finish Program 4x Without Adding Complexity
Scaling sterile fill-finish operations requires balancing tight clinical timelines with flexibility. Single-use formulation systems eliminate major capital costs, reduce cleaning burdens, and speed turnarounds without sacrificing product quality.
-
Navigating Large-Volume Subcutaneous Biologic Injections
Large-volume subcutaneous delivery is bringing biologic treatments closer to patients. Learn how advances in dosing and device technology are shaping care.
-
High-Dose Delivery: Integration And Performance
High-viscosity therapies bring new delivery challenges. Explore how needle, syringe, and device design affect injection performance, reliability, and user experience.
-
Flying On Two Wings: Balancing Local Agility And Global Quality In China
As China expands its role in drug development, injectable therapy programs face new demands. Learn how manufacturers are scaling quality, devices, and production for global success.